S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13
S&P 500   3,825.33
DOW   31,097.26
QQQ   282.13

Sinopharm Group Stock Forecast, Price & News

+0.06 (+0.50%)
(As of 07/1/2022 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
11,979 shs
Average Volume
35,481 shs
Market Capitalization
P/E Ratio
Dividend Yield
Price Target

Sinopharm Group Stock Forecast (MarketRank)

Analyst Rating
Short Interest
Dividend Strength
News Sentiment
Insider Trading
Proj. Earnings Growth

Overall MarketRank

MarketRank is calculated as 30% analysis score, 20% valuation score, 10% short interest score, 10% dividend score, 10% sustainability score, 10% news and social score, and 10% insider trading score.

0.59 out of 5 stars

30 days | 90 days | 365 days | Advanced Chart

Receive SHTDY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Sinopharm Group and its competitors with MarketBeat's FREE daily newsletter.

Sinopharm Group logo

About Sinopharm Group (OTCMKTS:SHTDY)

Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and healthcare products in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail drug stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices segment distributes medical devices. The Retail Pharmacy segment operates and franchises a network of retail drug stores. As of December 31, 2021, this segment had 10,259 retail pharmacies. The Other Business segment engages in the production and sale of pharmaceutical products, chemical reagents, and laboratory supplies. The company also rents and manages properties; distributes medical instruments, Chinese herbal medicines, antibiotics, and biological products; and offers information technology development and medicine consultation, investment, goods and technology import and export, business consultation, health consultation, medical consultation, market information consultation and investigation, and convention and exhibition services. In addition, it manages medical project investment, consulting, and technology training activities. Sinopharm Group Co. Ltd. has a strategic partnership with I-Mab to enhance its commercial capabilities and commercialization transformation. The company was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.

SHTDY Stock News Headlines

Sinopharm Group Co Ltd (1099)
Sinopharm Group Co. Ltd. ADR
UAE approves Sinopharm's protein-based vaccine
Starbucks Win Comes With Union Intimidation Complaints
See More Headlines

Industry, Sector and Symbol

Medical Distribution
Current Symbol
Year Founded


Pretax Margin


Sales & Book Value

Annual Sales


Free Float
Not Optionable

Sinopharm Group Frequently Asked Questions

How has Sinopharm Group's stock price performed in 2022?

Sinopharm Group's stock was trading at $10.81 on January 1st, 2022. Since then, SHTDY stock has increased by 12.3% and is now trading at $12.14.
View the best growth stocks for 2022 here

Are investors shorting Sinopharm Group?

Sinopharm Group saw a decrease in short interest in June. As of June 15th, there was short interest totaling 100 shares, a decrease of 93.3% from the May 31st total of 1,500 shares. Based on an average daily trading volume, of 45,900 shares, the days-to-cover ratio is presently 0.0 days.
View Sinopharm Group's Short Interest

Who are Sinopharm Group's key executives?

Sinopharm Group's management team includes the following people:
  • Mr. Qingming Yu, Exec. Chairman (Age 58, Pay $1M)
  • Mr. Yong Liu, Pres & Exec. Director (Age 53, Pay $998.75k)
  • Mr. Xiuchang Jiang, CFO & VP (Age 58)
  • Ms. Xiaojuan Li, Chief Financial Officer (Age 46)
  • Mr. Yijian Wu, Company Sec. (Age 52)
  • Mr. Wanyong Lian, VP (Age 51)
  • Mr. Shuangjun Xu, Non-Exec. VP (Age 53)
  • Mr. Maisong Cai, VP (Age 52)

What is Sinopharm Group's stock symbol?

Sinopharm Group trades on the OTCMKTS under the ticker symbol "SHTDY."

How do I buy shares of Sinopharm Group?

Shares of SHTDY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sinopharm Group's stock price today?

One share of SHTDY stock can currently be purchased for approximately $12.14.

How many employees does Sinopharm Group have?

Sinopharm Group employs 113,234 workers across the globe.

How can I contact Sinopharm Group?

Sinopharm Group's mailing address is Sinopharm Mansion, No. 1001 Zhongshan West Road, Changning District, Shanghai, Shanghai 200051. The official website for Sinopharm Group is www.sinopharmgroup.com.cn. The company can be reached via phone at 86 21 2305 2666.

This page (OTCMKTS:SHTDY) was last updated on 7/2/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer.